29 Jul 2026
AMEND USA President Featured by the Neuroendocrine Tumor Research Foundation
-
In this informative interview, John reflects on his journey as both a cancer researcher at the Cleveland Clinic and a patient living with MEN1 and metastatic pancreatic neuroendocrine tumors. John shares his insights on patient advocacy, the mission of AMEND USA, and the need for greater collaboration in MEN and neuroendocrine tumor research.
Dialogue like this will advance precision medicine, early detection, and lead to improved outcomes for patients.
John’s experience as both scientist and patient is a testament to the strength of the community and the impact patients, researchers, clinicians, and advocates have when working together.
Thank you to the Neuroendocrine Tumor Research Foundation for featuring John’s story and for their commitment to advancing neuroendocrine tumor research and supporting the patient community.
We invite you to read the full interview and learn more about John’s research, advocacy, and vision for the future of the MEN community.
-
John Metzcar